TJ-RO4B

N/A

Report date: 2026/01/29 14:45:04

Base Information

Drug NameTJ-RO4B
Drug Alias NameTJ-RO4B
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibody
Mechanisms of ActionAnti-Inactive tyrosine-protein kinase transmembrane receptor ROR1Tumor necrosis factor receptor superfamily member 9 agonists
TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1Tumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesI-Mab Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesI-Mab Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A